All relevant data are within the paper and its Supporting Information files.

Introduction {#sec005}
============

TB, an infectious disease primarily caused by *Mycobacterium tuberculosis* (*M*. *tuberculosis*), is a growing global public health problem. According to the World Health Organization, approximately one-third of the world's population is infected with *M*. *tuberculosis*, though only 10% of individuals who are infected by the pathogen will develop clinical disease \[[@pone.0127496.ref001]\]. These data suggest that, in addition to *M*. *tuberculosis* itself, the development of TB after infection may also involve certain host factors, such as host immunity and genetics \[[@pone.0127496.ref002]\].

IL-10, which is expressed by activated monocytes/macrophages, natural killer (NK) cells, dendritic cells (DCs), mast cells, B cells, and regulatory T cell subsets, is known to have macrophage-deactivating properties and undermines the Th1-driven pro-inflammatory response by down-regulating the production of several cytokines. O\'Leary et al. demonstrated that in macrophages, IL-10 may prevent phagosome maturation, thus leading to *M*. *tuberculosis* persistence in humans \[[@pone.0127496.ref003]\]. Several studies have also reported high levels of IL-10 production in TB patients \[[@pone.0127496.ref004],[@pone.0127496.ref005]\]. Furthermore, in mouse models, over-expression of IL-10 may affect the recurrence of latent TB but shows little effect on susceptibility to primary infection \[[@pone.0127496.ref006]\]. These results indicate that the IL-10 gene and its gene product, IL-10, play a critical role in susceptibility to and pathogenesis of TB.

The IL-10 gene maps to chromosome 1q31-32. The IL-10 promoter is highly polymorphic, and three single nucleotide polymorphisms (SNPs) at positions -1082, -819, and -592 within the promoter region have been shown to correlate with IL-10 production \[[@pone.0127496.ref007]\]. Meanwhile, these polymorphisms exhibit strong linkage disequilibrium. Previous in vitro studies showed that the GCC haplotype of peripheral blood mononuclear cells was related to abundant IL-10 production, whereas the ATA haplotype was correlated with low levels of IL-10 production \[[@pone.0127496.ref007]--[@pone.0127496.ref011]\].

To date, many genetic epidemiology studies have assessed the association between IL-10 gene polymorphisms and the risk of TB in different populations \[[@pone.0127496.ref002],[@pone.0127496.ref012]--[@pone.0127496.ref038]\]. However, the results from these studies were often inconsistent and inconclusive. This inconsistency may derive from a number of issues, including false-positive errors, lack of power, and minor impacts of IL-10 gene polymorphisms on TB susceptibility \[[@pone.0127496.ref039]\]. A meta-analysis is defined as research that analyzes previous research. Hence, results from previously published studies are gathered and statistically analyzed \[[@pone.0127496.ref040]\]. The purpose of the present study was to identify patterns among variant results, to find the sources of any inconsistencies among those results, and to eliminate the effects of random errors that are responsible for false-positive or false-negative interactions. Although there are already three published meta-analyses on these polymorphisms \[[@pone.0127496.ref041],[@pone.0127496.ref042],[@pone.0127496.ref043]\], confusing results remain unresolved. Furthermore, two of the previous studies failed to test the Hardy-Weinberg equilibrium (HWE). Liang B. et al. considered the HWE but still included those studies that were not consistent with the HWE \[[@pone.0127496.ref043]\]. Deviation from the HWE among the controls implies either a potential bias during control selection or genotyping errors. Moreover, Liang B. et al. missed four studies \[[@pone.0127496.ref029], [@pone.0127496.ref033]--[@pone.0127496.ref034], [@pone.0127496.ref036]\] and also incorporated repeated articles into their meta-analysis, such as Ansari A. et al. (2009) and Ansari A. et al. (2011) and Selvaraj P. et al. (2008) and Prabhu Anand S. et al. (2007). Therefore, we performed a meta-analysis of all eligible studies to derive a more precise estimation of the associations between IL-10 polymorphisms and TB risk.

Methods {#sec006}
=======

Publication search {#sec007}
------------------

An elaborate search was conducted for studies that examined the association between IL-10 polymorphisms and TB \[[@pone.0127496.ref040]\]. Two independent reviewers (Gao and Chen) searched PUBMED, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), Wanfang databases and the Chinese National Knowledge Infrastructure (CNKI) to identify available studies that were published by August 2014 \[[@pone.0127496.ref040]\]. The heading (MeSH) terms and/or text words used were as follows: 'tuberculosis or *Mycobacterium tuberculosis*' in combination with 'interleukin 10 or interleukin-10 or IL-10 or IL 10' and 'polymorphism or variant or genetic or SNP'. We also perused the reference lists of all retrieved articles and relevant reviews. If the full text article could not be obtained from the databases, we tried to contact the authors. There were no restrictions placed on language, race, ethnicity or geographic area \[[@pone.0127496.ref043]\].

Study selection and data extraction {#sec008}
-----------------------------------

Studies were included in this meta-analysis if they met the following criteria: (1) studies that evaluated IL-10 gene polymorphisms and TB risk; (2) case-control studies; (3) studies that provided sufficient data to calculate an OR and a 95% CI. Studies were excluded if they (1) contained overlapping data; (2) were based on families; (3) did not provide the numbers of null and wild-type genotypes or alleles; (4) were editorials, reviews, or abstracts; or (5) were not consistent with HWE.

Data were extracted from original studies independently by two reviewers (Gao and Chen). Any discrepancies between the reviewers were resolved either by reaching a consensus or by a third reviewer (Yao). The following information was collected from each study: the name of the first author, the year of publication, the originating country, ethnicity, types of TB infection and controls, human immunodeficiency virus (HIV) status, the number of cases and controls, and genotype and allele frequency information. We verified the accuracy of the data by comparing the collection forms from each investigator.

Statistical analysis {#sec009}
--------------------

When data from at least 5 similar studies were available, meta-analysis was performed. The summary ORs and 95% CIs were used to measure the strength of the associations between IL-10 polymorphisms and TB susceptibility \[[@pone.0127496.ref039]\]. The statistical significance of the summary ORs was evaluated using the Z test. For each SNP, we established four genetic models to evaluate their association with TB risk: (1) allelic contrast; (2) variant homozygote genotype vs. wild-type homozygote genotype; (3) dominant model: variant homozygote combined with a heterozygote genotype versus wild-type homozygote genotype, and (4) recessive model: variant homozygote genotype versus heterozygote and wild-type homozygote genotypes.

The heterogeneity between studies was assessed using the chi-square-based Cochrane Q-test, which was considered to be significant when P\<0.10 \[[@pone.0127496.ref044]\]. The fixed-effect model shows that the similar impact of genetic factors on TB susceptibility among variant studies are purely accidental, whereas the random-effect model indicates that dramatic diversity in assessment exists due to both intra-study sampling errors and inter-study variances \[[@pone.0127496.ref040], [@pone.0127496.ref045]\]. The fixed-effect model was chosen when the P value from the chi-square test was greater than 0.10; otherwise, the random-effect model was used \[[@pone.0127496.ref046]\]. To explore the source of the heterogeneity and to evaluate ethnicity-specific effects, subgroup analyses performed for IL-10 polymorphisms were investigated in a sufficient number of studies. Publication bias was assessed by visual inspection of funnel plots, in which the standard error of the log (OR) of each study was plotted against the log (OR). Funnel plot asymmetry was assessed using Egger's linear regression test \[[@pone.0127496.ref047]\]. Departure from HWE in the control group was assessed by the chi-square test, and a P-value \<0.05 was considered significant.

All statistical tests were performed using Review manager 5.2 (Nordic Cochrane Center, Copenhagen, Denmark) and STATA 12.0 (Stata Corporation, College Station, TX) software. P values \<0.05 were considered statistically significant.

Results {#sec010}
=======

Characteristics of included studies {#sec011}
-----------------------------------

The selection process of this literature review is summarized in the flow diagram ([Fig 1](#pone.0127496.g001){ref-type="fig"}). A total of 28 eligible articles fully met the inclusion criteria and were incorporated into this meta-analysis \[[@pone.0127496.ref002],[@pone.0127496.ref012]--[@pone.0127496.ref038]\]. Of these studies, five were performed in Europeans, five in Africans, three in Americans and 15 in Asians. [Table 1](#pone.0127496.t001){ref-type="table"} shows the characteristics of these studies, and [Table 2](#pone.0127496.t002){ref-type="table"} provides the detailed genotype frequencies and the HWE assessment results.

![Flow chart depicting the study selection process.](pone.0127496.g001){#pone.0127496.g001}

10.1371/journal.pone.0127496.t001

###### Characteristics of the case-control studies included in the meta-analysis.

![](pone.0127496.t001){#pone.0127496.t001g}

  Study \[Ref\]                               Year   Country       Ethnicity   Type of infection                                        Type of controls                              Cases(n)   Controls(n)   HIV status                                         SNPs
  ------------------------------------------- ------ ------------- ----------- -------------------------------------------------------- --------------------------------------------- ---------- ------------- -------------------------------------------------- ------------------------------------
  Bellamy \[[@pone.0127496.ref012]\]          1998   Gambia        African     Pulmonary TB                                             male donors                                   401        408           Negative                                           -1082G/A,-819C/T,-592C/A
  Lopez-Maderuelo\[[@pone.0127496.ref013]\]   2003   Spain         European    Pulmonary TB                                             healthy tuberculin-negative volunteers        113        100           Negative                                           -1082G/A
  Fitness \[[@pone.0127496.ref014]\]          2004   Malawi        African     TB                                                       individually matched controls                 514        913           Positive in 50% of cases and negative in control   -1082G/A,-819C/T
  Shin \[[@pone.0127496.ref015]\]             2005   Korea         Asian       Pulmonary TB                                             healthy controls                              459        871           Negative                                           -1082G/A,-819C/T,-592C/A,Haplotype
  Tso \[[@pone.0127496.ref002]\]              2005   China         Asian       Pulmonary and extrapulmonary TB                          healthy donors                                385        471           Negative                                           Haplotype
  Amirzargar \[[@pone.0127496.ref016]\]       2006   Iran          Asian       Pulmonary TB                                             healthy donors                                41         123           NA                                                 -819C/T,-592C/A
  Oral \[[@pone.0127496.ref016]\]             2006   Turkey        European    Pulmonary, or pleural, other extrapulmonary TB           healthy donors                                81         50            NA                                                 -1082G/A,-819C/T,-592C/A,Haplotype
  Ma \[[@pone.0127496.ref019]\]               2007   China         Asian       Pulmonary TB                                             healthy controls                              40         40            NA                                                 -1082G/A
  Oh \[[@pone.0127496.ref018]\]               2007   Korea         Asian       Pulmonary TB                                             healthy adults                                145        117           Negative                                           -1082G/A
  Ates \[[@pone.0127496.ref020]\]             2008   Turkey        European    Pulmonary and extrapulmonary TB                          healthy individuals                           128        80            NA                                                 -1082G/A,-819C/T,-592C/A,Haplotype
  Selvaraj \[[@pone.0127496.ref021]\]         2008   India         Asian       Pulmonary TB                                             healthy subjects                              166        188           Negative                                           -1082G/A,-819C/T
  Wu \[[@pone.0127496.ref022]\]               2008   China         Asian       Pulmonary TB                                             miners with no TB                             61         122           NA                                                 -1082G/A,-819C/T,-592C/A,Haplotype
  Moller \[[@pone.0127496.ref023]\]           2009   SouthAfrica   African     TB                                                       healthy individuals with no TB                432        482           Negative                                           -1082G/A,-819C/T,-592C/A,Haplotype
  Thye \[[@pone.0127496.ref024]\]             2009   Ghana         African     Pulmonary TB                                             cases with no TB contact                      2010       2346          Negative                                           -1082G/A,-819C/T,-592C/A
  Trajkov \[[@pone.0127496.ref025]\]          2009   Macedonia     European    TB                                                       healthy individuals                           75         301           NA                                                 -819C/T,-592C/A
  Taype \[[@pone.0127496.ref026]\]            2010   Peru          American    Pulmonary, or pleural, miliary other extrapulmonary TB   healthy control                               626        513           NA                                                 -1082G/A,-592C/A
  Yang \[[@pone.0127496.ref027]\]             2010   China         Asian       Pulmonary TB                                             healthy subjects                              200        200           NA                                                 -1082G/A
  Akgunes \[[@pone.0127496.ref028]\]          2011   Turkey        European    Pulmonary TB                                             healthy donors                                30         30            NA                                                 -1082G/A,-819C/T,-592C/A
  Ben-Selma \[[@pone.0127496.ref029]\]        2011   Tunisia       African     Pulmonary and extrapulmonary TB                          healthy donors                                131        95            Negative                                           -819C/T,-592C/A
  Liang L \[[@pone.0127496.ref030]\]          2011   China         Asian       Pulmonary TB and TB pleurisy                             no history of TB or pleural disease           235        78            Negative                                           -1082G/A,-819C/T,-592C/A,Haplotype
  Ma Hui \[[@pone.0127496.ref032]\]           2012   China         Asian       Pulmonary TB                                             no TB contacts                                109        314           NA                                                 -1082G/A
  Ma MJ \[[@pone.0127496.ref033]\]            2012   China         Asian       Pulmonary TB                                             no TB controls                                923        1033          Negative                                           -1082G/A,-819C/T,-592C/A
  Mei \[[@pone.0127496.ref034]\]              2012   China         Asian       Pulmonary TB                                             healthy donors                                169        156           NA                                                 -592C/A
  Xin DS \[[@pone.0127496.ref035]\]           2012   China         Asian       Pulmonary TB                                             no TB history patients and healthy subjects   308        310           Negative                                           -1082G/A
  Ramaseri \[[@pone.0127496.ref031]\]         2012   India         Asian       Pulmonary and extrapulmonary TB                          healthy volunteers                            224        107           Positive in 47% of cases and negative in control   -1082G/A,-819C/T
  Garcia \[[@pone.0127496.ref036]\]           2013   Mexico        American    Pulmonary TB                                             donors and healthcare workers                 98         60            Negative                                           -1082G/A
  Meenakshi \[[@pone.0127496.ref037]\]        2013   India         Asian       TB                                                       healthy subjects                              100        100           NA                                                 -1082G/A
  Hutz MH \[[@pone.0127496.ref038]\]          2014   Paraguay      American    TB                                                       healthy individuals with no TB                38         58            NA                                                 -819C/T,-592C/A

TB = Tuberculosis, NA = data not available

10.1371/journal.pone.0127496.t002

###### Distribution of IL-10 genotypes in patients and controls.
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  Studies                                      TB    Control   HWE                      
  -------------------------------------------- ----- --------- ----- ----- ----- ------ -------
  -1082G/A                                                                              
  Akgunes \[[@pone.0127496.ref028]\]           6     9         15    0     13    17     0.130
  Ates \[[@pone.0127496.ref020]\]              26    65        37    6     32    42     0.978
  Bellamy \[[@pone.0127496.ref012]\]           51    185       165   45    184   179    0.824
  Fitness \[[@pone.0127496.ref014]\]           40    143       142   87    251   203    0.524
  Garcia \[[@pone.0127496.ref036]\]            60    29        9     31    25    4      0.768
  Liang L \[[@pone.0127496.ref030]\]           0     28        207   0     9     69     0.589
  Lopez-Maderuelo \[[@pone.0127496.ref013]\]   33    47        33    29    50    21     0.949
  Ma Hui \[[@pone.0127496.ref032]\]            29    35        45    32    130   152    0.591
  Ma MJ \[[@pone.0127496.ref033]\]             14    165       744   7     183   843    0.388
  Ma ZM \[[@pone.0127496.ref019]\]             2     16        22    1     6     33     0.292
  Meenakshi \[[@pone.0127496.ref037]\]         4     81        15    16    59    25     0.058
  Moller \[[@pone.0127496.ref023]\]            39    199       194   53    202   227    0.426
  Oh \[[@pone.0127496.ref018]\]                4     43        98    19    53    45     0.612
  Oral \[[@pone.0127496.ref017]\]              10    41        30    5     13    32     0.060
  Ramaseri \[[@pone.0127496.ref031]\]          12    62        136   2     43    57     0.057
  Selvaraj \[[@pone.0127496.ref021]\]          5     42        102   6     69    108    0.204
  Shin \[[@pone.0127496.ref015]\]              2     53        394   9     124   718    0.168
  Taype \[[@pone.0127496.ref026]\]             22    187       414   10    153   347    0.142
  Thye \[[@pone.0127496.ref024]\]              117   630       794   160   783   1025   0.542
  Wu \[[@pone.0127496.ref022]\]                1     12        48    0     18    104    0.379
  Xin DS \[[@pone.0127496.ref035]\]            248   55        5     249   60    1      0.185
  Yang \[[@pone.0127496.ref027]\]              3     26        169   1     44    155    0.253
  -819C/T                                                                               
  Akgunes \[[@pone.0127496.ref028]\]           19    10        1     11    13    6      0.553
  Amirzargar \[[@pone.0127496.ref016]\]        19    20        2     62    52    9      0.671
  Ates \[[@pone.0127496.ref020]\]              63    58        7     36    36    8      0.819
  Bellamy \[[@pone.0127496.ref012]\]           120   192       89    114   206   88     0.779
  Ben-Selma \[[@pone.0127496.ref029]\]         55    65        11    43    42    10     0.957
  Fitness \[[@pone.0127496.ref014]\]           178   220       60    287   303   108    0.062
  Liang L \[[@pone.0127496.ref030]\]           22    90        123   12    31    35     0.253
  Ma MJ \[[@pone.0127496.ref033]\]             58    256       229   61    253   230    0.491
  Moller \[[@pone.0127496.ref023]\]            207   186       39    201   229   52     0.267
  Oral \[[@pone.0127496.ref017]\]              48    23        10    24    19    7      0.320
  Ramaseri \[[@pone.0127496.ref031]\]          39    117       62    28    55    24     0.760
  Selvaraj \[[@pone.0127496.ref021]\]          24    86        45    45    82    56     0.174
  Shin \[[@pone.0127496.ref015]\]              39    173       238   91    384   376    0.631
  Thye \[[@pone.0127496.ref024]\]              514   763       267   665   942   365    0.329
  Trajkov \[[@pone.0127496.ref025]\]           35    35        5     155   125   19     0.348
  Wu \[[@pone.0127496.ref022]\]                3     34        24    10    62    50     0.125
  Hutz MH \[[@pone.0127496.ref038]\]           0     6         32    0     7     51     0.625
  -592A/C                                                                               
  Akgunes \[[@pone.0127496.ref028]\]           1     10        19    6     14    10     0.785
  Amirzargar \[[@pone.0127496.ref016]\]        2     20        18    9     52    62     0.671
  Ates \[[@pone.0127496.ref020]\]              7     58        63    8     36    36     0.819
  Bellamy \[[@pone.0127496.ref012]\]           89    192       120   88    206   114    0.779
  Ben-Selma \[[@pone.0127496.ref029]\]         12    63        56    10    42    43     0.957
  Liang L \[[@pone.0127496.ref030]\]           123   90        22    35    31    12     0.253
  Ma MJ \[[@pone.0127496.ref033]\]             370   432       121   440   476   117    0.491
  Mei \[[@pone.0127496.ref034]\]               56    81        32    26    79    51     0.622
  Moller \[[@pone.0127496.ref023]\]            39    186       207   51    230   201    0.213
  Oral \[[@pone.0127496.ref017]\]              10    23        48    7     19    24     0.320
  Shin \[[@pone.0127496.ref015]\]              238   173       39    376   384   91     0.631
  Taype \[[@pone.0127496.ref026]\]             117   218       264   105   230   178    0.055
  Thye \[[@pone.0127496.ref024]\]              172   532       321   269   696   480    0.551
  Trajkov \[[@pone.0127496.ref025]\]           5     31        39    28    117   154    0.403
  Wu \[[@pone.0127496.ref022]\]                24    34        3     50    62    10     0.125
  Hutz MH \[[@pone.0127496.ref038]\]           32    6         0     51    7     0      0.625

TB = Tuberculosis; HWE = Hardy-Weinberg equilibrium.

Twenty-two of the 28 articles studied the -1082G/A IL-10 polymorphism, 17 studied the -819C/T polymorphism, 16 studied the -592A/C polymorphism, and 6 studied IL-10 promoter haplotypes.

The IL-10-1082G/A polymorphism is not associated with TB susceptibility {#sec012}
-----------------------------------------------------------------------

The associations between the -1082G/A polymorphism and TB are shown in [Table 3](#pone.0127496.t003){ref-type="table"}. A total of 22 studies containing 6,699 TB patients and 7,679 controls were included in this meta-analysis. The results showed that the -1082G/A polymorphism was not associated with TB susceptibility under any genetic model. In addition, stratification by ethnicity revealed no association between the -1082G/A polymorphism and TB.

10.1371/journal.pone.0127496.t003

###### Meta-analysis of the association between the IL-10--1082 G/A polymorphism and TB.
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                               A vs. G            AA vs. GG   AA+AG vs. GG   AA vs. AG+GG                                                                                        
  ----------------------- ---- ------------------ ----------- -------------- ------------------ ------ ---------- ------------------ ------ ---------- ------------------ ------ ----------
  Overall                 22   0.97(0.85--1.11)   0.67        \<0.0001       0.88(0.63--1.24)   0.46   \<0.0001   0.87(0.65--1.15)   0.32   \<0.0001   1.00(0.84--1.19)   1.00   \<0.0001
  Subgroup by ethnicity                                                                                                                                                          
  Asian                   12   1.07(0.82--1.38)   0.63        \<0.0001       1.01(0.44--2.34)   0.98   \<0.0001   0.93(0.48--1.82)   0.83   \<0.0001   1.12(0.82--1.52)   0.48   \<0.0001
  European                4    0.62(0.36--1.07)   0.08        0.004          0.42(0.13--1.37)   0.15   0.008      0.55(0.24--1.26)   0.16   0.08       0.61(0.28--1.34)   0.22   0.003
  African                 4    1.01(0.91--1.11)   0.92        0.11           1.10(0.92--1.32)   0.30   0.26       1.11(0.93--1.32)   0.24   0.42       0.99(0.90--1.10)   0.88   0.23

TB = Tuberculosis; P~*Eff*~ = P value of pooled effect; P~*Het*~ = P value of heterogeneity test.

Association between the IL-10-819C/T polymorphism and TB susceptibility {#sec013}
-----------------------------------------------------------------------

The survey results regarding the associations between the -819C/T polymorphism and TB are shown in [Table 4](#pone.0127496.t004){ref-type="table"}. Our meta-analysis of the 17 case-control studies (5,024 TB patients and 6,180 controls) revealed that the -819C/T polymorphism was not associated with TB susceptibility under any genetic model.

10.1371/journal.pone.0127496.t004

###### Meta-analysis of the association between the IL-10 -819C/T polymorphism and TB.
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                               T vs. C            TT vs. CC   CT+TT vs. CC   TT vs. CT+CC                                                                                  
  ----------------------- ---- ------------------ ----------- -------------- ------------------ ------- ------ ------------------ ------- ------ ------------------ ------ ------
  Overall                 17   1.03(0.94--1.12)   0.57        0.04           1.01(0.89--1.14)   0.90    0.16   1.05(0.92--1.19)   0.46    0.09   1.01(0.92--1.11)   0.83   0.21
  Subgroup by ethnicity                                                                                                                                                    
  Asian                   7    1.17(1.05--1.29)   0.003       0.49           1.37(1.09--1.72)   0.006   0.67   1.33(1.09--1.63)   0.006   0.70   1.17(1.02--1.35)   0.03   0.32
  European                4    0.77(0.52--1.15)   0.20        0.07           0.61(0.34--1.11)   0.11    0.24   0.85(0.62--1.16)   0.30    0.16   0.66(0.37--1.17)   0.15   0.36
  African                 5    0.97(0.90--1.04)   0.33        0.64           0.91(0.79--1.06)   0.22    0.89   0.98(0.89--1.09)   0.74    0.32   0.91(0.80--1.04)   0.16   0.87

TB = Tuberculosis; P~*Eff*~ = P value of pooled effect; P~*Het*~ = P value of heterogeneity test.

Subgroup analysis by ethnicity revealed that the -819T allele was associated with increased TB risk in Asians under all genetic models (T vs. C: OR = 1.17, 95% CI = 1.05--1.29, P = 0.003; TT vs. CC: OR = 1.37, 95% CI = 1.09--1.72, P = 0.006; CT+TT vs. CC: OR = 1.33, 95% CI = 1.09--1.63, P = 0.006; TT vs. CT+CC: OR = 1.17, 95% CI = 1.02--1.35, P = 0.03). However, no association was found in Europeans or Africans under any genetic model.

Association of the IL-10-592A/C polymorphism with TB susceptibility {#sec014}
-------------------------------------------------------------------

The results of our meta-analysis of the association between the -592A/C polymorphism and TB are shown in [Table 5](#pone.0127496.t005){ref-type="table"}. A total of 16 case-control studies that examined the relationship between the -592A/C polymorphism and TB risk were included in this meta-analysis. The total number of cases and controls were 4,818 and 5,823, respectively. Meta-analysis revealed no remarkable association between the -592A/C polymorphism and TB in the selected samples.

10.1371/journal.pone.0127496.t005

###### Meta-analysis of the association between the IL-10 -592A/C polymorphism and TB.
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  Population                   A vs. C            AA vs. CC   AA vs. AC+CC   AA+AC vs. CC                                                                                  
  ----------------------- ---- ------------------ ----------- -------------- ------------------ ------ ------- ------------------ ------ ------- ------------------ ------ -------
  Overall                 16   0.99(0.87--1.12)   0.84        \<0.0001       0.99(0.79--1.25)   0.96   0.002   1.02(0.86--1.21)   0.79   0.006   1.02(0.86--1.20)   0.84   0.009
  Subgroup by ethnicity                                                                                                                                                    
  Asian                   6    1.22(0.96--1.55)   0.11        0.0004         1.50(0.89--2.53)   0.13   0.001   1.26(0.91--1.74)   0.17   0.002   1.32(0.94--1.85)   0.11   0.04
  European                4    0.77(0.60--0.98)   0.03        0.16           0.53(0.30--0.95)   0.03   0.38    0.59(0.33--1.03)   0.06   0.50    0.77(0.56--1.05)   0.10   0.21
  African                 4    0.96(0.88--1.04)   0.39        0.48           0.92(0.77--1.10)   0.36   0.81    0.91(0.77--1.07)   0.25   0.84    0.98(0.86--1.11)   0.73   0.18

TB = Tuberculosis; P~*Eff*~ = P value of pooled effect; P~*Het*~ = P value of heterogeneity test.

However, after stratification by different ethnicities, a significant association was found in Europeans using two genetic models (A vs. C: OR = 0.77, 95% CI = 0.60--0.98, P = 0.03; AA vs. CC: OR = 0.53, 95% CI = 0.30--0.95, P = 0.03); this association was not observed in Asians or Africans under any genetic model.

IL-10 promoter haplotype and TB {#sec015}
-------------------------------

Three SNPs in the promoter region (-1082G/A, -819C/T, -592A/C) were in complete linkage disequilibrium, and three haplotypes exist (GCC, ACC, and ATA). Six of the eligible case-control studies analyzed the relationship between the IL-10 promoter haplotype and the risk of TB ([Table 6](#pone.0127496.t006){ref-type="table"}). The results of pooling all studies demonstrated that the GCC haplotype was associated with an increased risk of TB (GCC vs. others: P = 1.42, 95% CI = 1.02--1.97, P = 0.04), but no association was found between the ACC and ATA haplotypes and TB risk. Furthermore, subgroup analyses based on ethnicity showed that the GCC haplotype was associated with an increased TB risk in Europeans, whereas the ACC haplotype was associated with a lower TB risk in both Asians and Europeans ([Table 6](#pone.0127496.t006){ref-type="table"}).

10.1371/journal.pone.0127496.t006

###### Meta-analysis of the association between IL-10 promoter haplotype (-1082G/A, 819C/T, 592A/C) and TB.

![](pone.0127496.t006){#pone.0127496.t006g}

  Population                  GCC vs. others                ACC vs. others       ATA vs. others                                                  
  ----------------------- --- ------------------ ---------- ---------------- --- ------------------ ------- ------ --- ------------------ ------ ------
  Overall                 6   1.42(1.02--1.97)   0.04       0.009            6   0.85(0.68--1.05)   0.14    0.02   5   0.90(0.78--1.04)   0.14   0.74
  Subgroup by ethnicity                                                                                                                          
   Asian                  3   1.30(0.93--1.82)   0.12       0.70             2   0.84(0.72--0.99)   0.04    0.78   2   1.04(0.79--1.38)   0.76   0.87
   European               2   2.14(1.53--3.01)   \<0.0001   0.80             2   0.60(0.43--0.83)   0.002   0.39   2   0.78(0.56--1.09)   0.15   0.77

TB = Tuberculosis; P~*Eff*~ = P value of pooled effect; P~*Het*~ = P value of heterogeneity test.

Heterogeneity and publication bias {#sec016}
----------------------------------

Some intra-study heterogeneity was observed during the meta-analyses, but no evidence suggested heterogeneity between the significant associations, except for the GCC haplotype as a whole. This heterogeneity was eliminated after stratification by ethnicity. The funnel plots for these polymorphisms in all compared models were symmetrical ([Fig 2](#pone.0127496.g002){ref-type="fig"} shows the funnel plot for -592A/C in the allele model). The results of the Egger's test did not suggest obvious publication bias for the -819C/T variant (P = 0.711 for T vs. C, P = 0.949 for TT vs. CC, P = 0.533 for CT+TT vs. CC, P = 0.173 for TT vs. CT+CC). Similarly, no publication bias was detected for the associations between the -1082G/A and -592A/C polymorphisms and TB.

![Funnel plot for -592A/C in the allele model.](pone.0127496.g002){#pone.0127496.g002}

Discussion {#sec017}
==========

It is currently believed that host genetic factors are of vital importance in the pathogenesis of TB, as host genetic factors affect the expression levels of cytokines and chemokines that are known to participate in host immunity \[[@pone.0127496.ref048]\]. As a powerful Th2-regulatory cytokine, IL-10 plays an essential role during the latent stage of TB infection. The long arm of chromosome 1, where the IL-10 gene is situated, contains known polymorphisms within the IL-10 promoter region, including -1082G/A, -819T/C, and -592A/C \[[@pone.0127496.ref043]\]. Furthermore, IL-10 is reportedly associated with TB in different ethnic backgrounds \[[@pone.0127496.ref049]\].

The meta-analysis performed by Zhang J. et al. reported that the -1082G/A polymorphism correlated significantly with a downside risk of TB in Europeans, whereas the IL-10 -819T/C and -592A/C polymorphisms were unrelated to TB susceptibility \[[@pone.0127496.ref041]\]. Similarly, another meta-analysis by Liang B. et al. confirmed that the risk for TB was independent of the -1082G/A, -819T/C, and -592A/C genotypes in the gross population but showed that the risk was dramatically reduced in the -1082G/A genotype in Europeans and Americans and was significantly associated with the -819T/C polymorphism in Asians \[[@pone.0127496.ref043]\].

However, in our meta-analysis, no association was revealed between the IL-10-1082G/A, -819T/C and -592A/C polymorphisms and TB susceptibility from 22 studies with 6,699 TB patients and 7,679 controls, 17 studies with 5,024 TB patients and 6,180 controls, and 16 studies with 4,818 cases and 5,823 controls, respectively. According to our subgroup analyses by ethnicity, no association was revealed between the -1082G/A polymorphism and TB. Additionally, the -819T allele was found to be associated with an increased risk of TB in Asians under all genetic models, whereas two genetic models (A vs. C; AA vs. CC) of the association between the -592A/C polymorphism and TB showed significant associations in Europeans. Several reasons may explain why our results differ from those of Zhang J. et al. and Liang B. et al. First, we only incorporated studies that were consistent with HWE. Second, our work was an update to the work of other groups, which allowed for the inclusion of some new studies. As a result, our conclusions may be more scientific. Taken together, our results suggest that ethnic differences may play an important role in environmental and genetic factors.

We also analyzed the association between IL-10 promoter haplotypes and TB risk. In our meta-analysis of 6 studies, only the GCC haplotype was associated with an increased TB risk. Moreover, subgroup analyses based on ethnicity showed that the GCC haplotype was associated with an increased TB risk in Europeans, whereas the ACC haplotype was associated with a lower TB risk in both Asians and Europeans, suggesting that ethnic differences may play a role in the association between IL-10 promoter haplotypes and TB risk.

As an indispensable tool, genome-wide association studies (GWASs) are being used more and more for the identification of common variants that are associated with a variety of diseases. To date, many GWASs have successfully identified TB susceptibility genes \[[@pone.0127496.ref050]--[@pone.0127496.ref058]\]. These genes include the interferon-gamma gene (*IFNG*), the vitamin D receptor gene (*VDR*), and the interleukin-12 p40 subunit gene (*IL12B*), among others \[[@pone.0127496.ref052], [@pone.0127496.ref057]\]. However, these studies provided no direct evidence to prove an association between TB and the IL-10 gene. Furthermore, GWASs of TB are ongoing, which indicates that TB has not been adequately studied by modern genomic technologies \[[@pone.0127496.ref059]\]. Many of the associated genes have not yet been studied. With an increased number of GWASs studying TB, more related genes will be found, and IL-10 is only one gene. Therefore, with respect to genome-wide associations and TB, much work remains to be done.

Two of the selected studies in our meta-analysis considered the impact of HIV status on susceptibility to TB \[[@pone.0127496.ref014], [@pone.0127496.ref031]\]. However, many researchers have focused on this issue. Their studies have found that, compared to HIV-negative controls, HIV-positive patients showed greater susceptibility to TB \[[@pone.0127496.ref060]\]. Especially in sub-Saharan Africa, which has the highest HIV morbidity worldwide, HIV-positive persons showed a 20-fold increased risk over HIV-negative individuals of developing TB \[[@pone.0127496.ref061]\]. An increasing number of studies have begun to investigate the mechanism of how HIV infection influences susceptibility to TB. It was reported that antigens such as HLA-A31 and HLA-B41, chemokine receptors such as CCR5, and the -1082G allele of IL-10 were involved in TB susceptibility \[[@pone.0127496.ref031], [@pone.0127496.ref062]--[@pone.0127496.ref063]\]. However, the exact mechanism remains unclear, and additional studies are needed to clarify this issue.

Although some intra-study heterogeneity was detected for these polymorphisms during the meta-analyses, no evidence of heterogeneity was found for the significant associations. After subgroup analyses by ethnicity, the heterogeneity disappeared. This suggests that ethnicity may be the main source of heterogeneity. Furthermore, we generated funnel plots and carried out Egger's tests to evaluate the existence of publication bias; no publication bias was observed in our study.

Several limitations should be considered when interpreting our results. First, additional studies are needed to complete a comprehensive analysis, especially for the IL-10 promoter haplotype \[[@pone.0127496.ref064]\]. Furthermore, after stratification by ethnicity, there were only a small number of studies in the European subgroup, which may reduce the strength of our conclusions. Second, different diagnostic criteria of TB and controls across studies may affect the comparability of the studies or lead to the misclassification of cases. The studies that were selected for this meta-analysis did not have unified diagnostic criteria, which may result in misclassification bias \[[@pone.0127496.ref059]\]. Third, the evaluation of our analysis is unadjusted. However, the accuracy of our evaluation with respect to the effects of gene-gene and gene-environment associations in TB has been compromised due to the limited amount of original data from the qualified studies \[[@pone.0127496.ref064]\].

In conclusion, this meta-analysis suggested that the IL-10-819T/C polymorphism was associated with TB risk in Asians and that the IL-10-592A/C polymorphism may be a risk factor for TB in Europeans. IL-10 promoter haplotypes play a vital role in the susceptibility to or protection against the development of TB. To further establish these associations, future studies with larger sample sizes and multi-ethnic sample groups are required.
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